The substantial beat on both the EPS and sales estimates for Vital Farms in Q1 2024 suggests that the company is performing significantly better than expected. This outperformance, especially in the context of surpassing sales estimates by a notable margin, could lead to increased investor confidence and a positive short-term impact on the stock price. The fact that the EPS reported is more than double the estimate may lead to a reassessment of the company's valuation by the market.